TOWA Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2026 was $2,995 Mil.
During the past 12 months, TOWA Pharmaceutical Co's average Total Assets Growth Rate was 1.10% per year.
During the past 3 years, the average Total Assets Growth Rate was 7.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 13.70% per year.
During the past 10 years, the average Total Assets Growth Rate was 14.60% per year.
During the past 13 years, TOWA Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 24.00%. The lowest was 4.80%. And the median was 13.60%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
TOWA Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
TOWA Pharmaceutical Co Total Assets Related Terms
TOWA Pharmaceutical Co Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
TOWA Pharmaceutical Co's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TOWA Pharmaceutical Co (TWAPF) has a Total Assets of $2,995 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Total Assets too high?
TOWA Pharmaceutical Co's current Total Assets is $2,995 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Total Assets compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Total Assets of $2,995 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Total Assets is $2,995 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
TOWA Pharmaceutical Co (TWAPF) has a current Total Assets of $2,995 Mil. The stock's GF Value™ is $15.06, compared to a current price of $16.83 — trading 11.8% above its estimated fair value. The current Total Assets is $2,995 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Total Assets is $2,995 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued.
The current stock price of $16.83 is trading 11.8% above its estimated GF Value™ of $15.06.
Key valuation signals for TWAPF:
Total Assets: $2,995 Mil
GF Value™: $15.06 vs. price of $16.83 (11.8% above fair value)
No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
86GF Score
Get the complete analysis for TWAPF
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TWAPF has been successfully added to your 
